Dr. Arpeet Shah
Urologist
1 Podcast • 1 Course on BackTable
Dr. Arpeet Shah is a urologist at Associate Urological Specialists in Chicago, Illinois.
Learn from the experiences and expertise of Dr. Arpeet Shah and other leading voices in your specialty on the BackTable app.
Episode # 190 • 24 Sept 2024
Optimizing BPH Care: Insights from Physician-APP Collaboration
Learn how Advanced Practice Providers (APPs) can boost workflow efficiency and improve patient experience in your urology practice. In this episode of the BackTable Urology podcast, host Dr. Jose Silva speaks with Dr. Arpeet Shah and advanced practice nurse (APN) Nicole Hollander, about the role of APPs in benign prostate hyperplasia (BPH) patient care.
This podcast is supported by
More from Dr. Arpeet Shah
Loading recent podcasts…
About
Dr. Shah brings a wealth of leading-edge knowledge and experience to his compassionate care. He is a fellowship trained, board-certified urologist with a particular interest in robotic and minimally invasive urological surgery. He performs complex robotic procedures including prostatectomy, cystectomy, nephrectomy, partial nephrectomy, nephroureterectomy, pyeloplasty, and ureteral reimplantation. He also has an interest in minimally invasive BPH procedures including Rezum, UroLift, Greenlight PVP, Aquablation and robotic simple prostatectomy. He has achieved a Center Of Excellence distinction for Rezum and is a clinical instructor for Boston Scientific's BPH division.
Alongside his clinical role, Dr. Shah is on the AUS leadership team and serves as the Director of APP Program. Dr. Shah also serves as a member of the National Clinical Board of Solaris, a national urology platform, as well as the Chair of the Future Leaders Committee for the Solaris Health Board. He also is on the Robotic Surgical Committee at Advocate South Suburban Hospital and the Surgical Quality Committee at University of Chicago Ingalls Memorial Hospital.
His collegiate education began as part of the prestigious Guaranteed Professional Program Admissions (GPPA) Medical Scholars Program at University of Illinois at Chicago where he completed his Bachelor in Sciences in Biology summa cum laude. He then completed his Doctorate in Medicine at University of Illinois at Chicago with a distinctive honor of being a member of the Urban Medicine Program. He then went on to Loyola University Medical Center and completed his internship in general surgery, residency in urology, and fellowship in robotic surgery and endourology. A true asset to his field, he is board-certified in urology by the American Board of Urology (ABU).
This BackTable podcast is sponsored by Boston Scientific’s Urology Division. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world; this includes solutions for Benign Prostatic Hyperplasia or BPH, one of the most prevalent urologic conditions facing men today. [1,2]
Boston Scientific’s RezūmTM Water Vapor Therapy is a minimally invasive BPH treatment that provides urologists with an efficient, durable solution that reduces prostate volume while preserving sexual function. [3,4] With proven efficacy, durability, and lower clinical progression rates than daily medications, AUA guidelines support a shared decision-making process for the consideration of RezūmTM as a first-line treatment and alternative to medications. [3,5,6] Additionally, if insufficiently treated, BPH can negatively
impact bladder function, making earlier intervention valuable for patients. [7] Give your patients an alternative to daily medications and long-lasting BPH relief with Rezum Therapy.
1. AUA Annual Census Report – 2021, https://www.auanet.org/research-and-data/aua-census
2. Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, Te AE, Kaplan SA. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2016
May 5;2:16031. doi: 10.1038/nrdp.2016.31. PMID: 27147135
3. McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of Rezūm water
vapor thermal therapy for treatment of moderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J
Urol. 2021 Sep;206(3):715-24.
4. Mynderse LA, Hanson D, Robb RA, et al. Rezūm System water vapor treatment for lower urinary tract symptoms/benign prostatic
hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional
renderings. Urology. 2015 Jul;86(1):122-7.
5. Gupta N, Rogers T, Holland B, et al. Three-year treatment outcomes of water vapor thermal therapy (Rezūm System) compared to
doxazosin, finasteride and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the Medical Therapy of
Prostatic Symptoms (MTOPS) Trial. J Urol. 2018 Aug;200(2):405-13.
6. Lerner LB, McVary, KT, Barry MJ et al: Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA
Guideline. J Urol 2021; 206: 806.
7. Mirone V, Imbimbo C, Longo N, Fusco F. The Detrusor Muscle: An Innocent Victim of Bladder Outlet Obstruction. J Eur Uro. 2007, Vol 51
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
All trademarks are the property of their respective owners.
©2023 Boston Scientific Corporation or its affiliates. All rights reserved. URO-1540313-AA MAR 2023
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.